I n HIV-infected patients with severe immune deficiency, the initiation of highly active antiretroviral therapy (HAART) is followed by an excessive inflammatory response, resulting in the suppression of HIV replication, an increase in blood CD4-T cells count and the restoration of pathogenspecific immune responses. 1 We report a case of immune reconstitution inflammatory syndrome (IRIS) revealed by an acute decline in kidney function in an HIV-infected patient with disseminated tuberculosis.
Case Report
Investigation of disseminated tuberculosis revealed HIV-1 and HCV coinfection in a 51-year-old Chinese man. The sites of Mycobacterium tuberculosis infection were pulmonary, hepatic, and cutaneous. Because there was neither leukocyturia nor This study reports the case of an HIV-infected patient with disseminated tuberculosis who presented an immune reconstitution inflammatory syndrome (IRIS) revealed by an acute kidney disease 45 and 15 days after initiation of antituberculosis therapy and HAART, respectively. Prednisone therapy and the transient withdrawal of HAART improved the renal function and the clinical condition of this patient. All published case reports of IRIS revealed by acute renal failure in HIVinfected patients are also reviewed.
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(326 cells/mm 3 ), and the RNA viral load dropped to 494 copies/mL. Other investigations, including stool and blood cultures, cryoglobulinemia, were negative. Kidney biopsy revealed a diffuse and intense granulomatous tubulointerstitial nephritis without caseous necrosis and glomerular lesion ( Figure 1 ). Ziehl staining , as well as immunofluorescence analysis, was negative. There was nonglomerular lesion and immunofluorescence analysis was negative.
The diagnosis of IRIS was made because of the occurrence of acute kidney disease with compatible histological features in an HIV-infected patient with disseminated tuberculosis and dramatical immune restoration after the introduction of HAART. Tenofovir-related renal toxicity was excluded by the findings above and because no hypophosphatemia or glycosuria were found.
Ethambutol, pyrazinamide, and HAART were stopped and rifampicin and isoniazid doses adapted to the renal function. Prednisone therapy was introduced at 1 mg/kg per day (50 mg). The creatinine level increased to 750 μmol/L and then slowly decreased to 250 μmol/L but stayed at this level. Because of the potential interaction between steroids and rifampicin, we decided to increase the dose of steroids to 1.5 mg/kg per day (70 mg), which produced a slow improvement of renal function and allowed the reintroduction of pyrazinamide. HAART was restarted 3½ months after the initiation of steroid therapy (lamivudine, zidovudine, and efavirenz). No opportunistic infection occurred during prednisone therapy and steroids were progressively stopped (total duration: 6 months). Currently, after a follow-up of 8 months, the patient is still receiving HAART and antituberculosis therapy and has a good clinical condition. The creatinine level is 97 μmol/L (estimated GFR: 55 mL/min), the CD4 cell count is 310 cells/ mm 3 , and the plasma RNA viral load is undetectable. The evolution of creatinine level, the CD4-cell count, and the RNA viral load is summarized in Figure 2 .
Discussion
Acute kidney disease rarely reveals IRIS. To date only 4 cases, all in patients with mycobacterial infections, have been reported in the literature [2] [3] [4] and they are summarized in Table 1 . In these cases, IRIS reflects efficient immune recovery following the initiation of HAART, thus the capacity for immune response to mycobacterial antigens. Indeed, this syndrome occurred in severely immunodeficient antiretroviral (ARV)-naive HIV positive patients with mycobacterial coinfection, as a response to HAART. The delay after the initiation of HAART was variable (from 4 days to 4 months, median 2 months). Only 1 patient had a mycobacterial urinary localization. 2 Usually, renal injury was accompanied by other IRIS-related symptoms such as fever, worsening of pulmonary infiltrates and cholestasis, a finding not observed in the present case. [2] [3] [4] The diagnosis of IRIS was based on the histological features of kidney biopsies showing an acute insterstitial nephitis with or without granulomata, increase of CD4 cell count and also a dramatic decrease in the serum RNA viral load. The management of IRIS-related acute kidney disease includes high dose of prednisone (1 mg/kg per day) for a few weeks followed by a tapering dosage. In all cases, this regimen leads to complete improvement of the renal function. HAART was usually continued. However, in our case, antiretroviral therapy was withdrawn because of the severity of the renal failure and the severe histological lesions. Antiretroviral therapy was restarted 3½ months later because of the slow improvement of the renal function.
The prevalence of IRIS ranges between 25% and 31.7% in retrospective studies. 1, 5 This syndrome also occurs in HIV-positive patients mainly coinfected with cryptococcosis, cytomegalovirus, zoster, herpes, and HPV. 1, 6 It usually occurred within the first 8 weeks of HAART. 1, 7 In a retrospective study of 180 HIV-infected patients with opportunistic infections (OIs; tuberculosis, mycobacterium avium complex, and cryptococcosis), the predictive factors for IRIS were male gender (P = .02), ARV-naive patients at the time of diagnosis of their OI (P < .001), a short interval (less than 50 days) between the initiation of OI treatment and the beginning of HAART (P < .001), and the dramatic decrease of the RNA viral load in the first 3 months of treatment (P < .001) but not an increase in the CD4 cell count. 5 Delaying the time to HAART initiation in patients treated for mycobacterial infection might theoretically decrease the risk of IRIS and clinical trials are in progress to address this issue. The management of this syndrome usually consists in steroid therapy with continuing ARV drugs and specific treatment of OI although no clinical trial has been performed yet. 6 This case report is a reminder that the initiation of HAART in severely immunodeficient HIV-infected patients with mycobacterial infection requires careful monitoring of renal function because of the risk of IRIS, especially during the first months of HAART.
